{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:48:09Z","timestamp":1789012089085,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s10194-018-0896-5","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T04:06:57Z","timestamp":1535688417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)"],"prefix":"10.1186","volume":"19","author":[{"name":"on behalf of the European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-1939","authenticated-orcid":false,"given":"Simona","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele S.","family":"Merki-Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Lehrmann","family":"\u00c6gidius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas R.","family":"Gantenbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lampl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8jvind","family":"Lidegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Anne MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos-Dimitrios","family":"Mitsikostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella Elena","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ntaios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Paemeleire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Morten","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela Marie","family":"Terwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti Gr\u00f8tta","family":"Vetvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"896_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S1474-4422(04)00768-9","volume":"3","author":"EA MacGregor","year":"2014","unstructured":"MacGregor EA (2014) Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3:354\u2013361","journal-title":"Lancet Neurol"},{"key":"896_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","volume":"16","author":"KG Vetvik","year":"2017","unstructured":"Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16:76\u201387","journal-title":"Lancet Neurol"},{"key":"896_CR3","unstructured":"Ripa P, Ornello R, Degan D, Tiseo C, Stewart J, Pistoia F, Carolei A, Sacco S (2015) Migraine in menopausal women: a systematic review. Int J Womens Health 7:773\u2013782"},{"key":"896_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10194-012-0424-y","volume":"13","author":"S Sacco","year":"2012","unstructured":"Sacco S, Ricci S, Deagn D, Carolei A (2012) Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain 13:177\u2013189","journal-title":"J Headache Pain"},{"key":"896_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1526-4610.2005.05049.x","volume":"45","author":"EW Loder","year":"2005","unstructured":"Loder EW, Buse DW, Golub JR (2005) Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache 45:224\u2013231","journal-title":"Headache"},{"key":"896_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/0333102417710636","volume":"38","author":"S Warhurst","year":"2018","unstructured":"Warhurst S, Rofe CJ, Brew BJ, Bateson D, McGeechan K, Merki-Feld GS, Garrick R, Tomlinson SE (2018) Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia 38:754\u2013764","journal-title":"Cephalalgia"},{"key":"896_CR7","unstructured":"Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia S(supp17):20"},{"issue":"Suppl 1","key":"896_CR8","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9\u2013160","journal-title":"Cephalalgia"},{"key":"896_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"896_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1\u2013211","journal-title":"Cephalalgia"},{"key":"896_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2165\/11538090-000000000-00000","volume":"70","author":"EA MacGregor","year":"2010","unstructured":"MacGregor EA (2010) Prevention and treatment of menstrual migraine. Drugs 70:1799\u20131818","journal-title":"Drugs"},{"key":"896_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1526-4610.2003.03065.x","volume":"43","author":"V Martin","year":"2003","unstructured":"Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S, Liu J, Ramadan N, Rebar R (2003) Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 43:309\u2013321","journal-title":"Headache"},{"key":"896_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2014.05.016","volume":"179","author":"M Morotti","year":"2014","unstructured":"Morotti M, Remorgida V, Venturini PL, Ferrero S (2014) Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. Eur J Obstet Gynecol Reprod Biol 179:63\u201368","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"896_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejogrb.2014.10.029","volume":"183","author":"M Morotti","year":"2014","unstructured":"Morotti M, Remorgida V, Venturini PL, Ferrero S (2014) Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. Eur J Obstet Gynecol Reprod Biol 183:178\u2013182","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"896_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","volume":"47","author":"P Sulak","year":"2007","unstructured":"Sulak P, Willis S, Kuehl T, Coffee A, Clark J (2007) Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47:27\u201337","journal-title":"Headache"},{"key":"896_CR16","first-page":"1503","volume":"347","author":"A Carolei","year":"1996","unstructured":"Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council study group on stroke in the young Lancet 347:1503\u20131506","journal-title":"The Italian National Research Council study group on stroke in the young Lancet"},{"key":"896_CR17","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2016.12.019","volume":"216","author":"SW Champaloux","year":"2017","unstructured":"Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ (2017) Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol 216:489.e1\u2013489.e7","journal-title":"Am J Obstet Gynecol"},{"key":"896_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.318.7175.13","volume":"318","author":"CL Chang","year":"1999","unstructured":"Chang CL, Donaghy M, Poulter N (1999) Migraine and stroke in young women: case\u2013control study. The World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception. BMJ 318:13\u201318","journal-title":"BMJ"},{"key":"896_CR19","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1161\/STROKEAHA.107.488395","volume":"38","author":"LR MacClellan","year":"2007","unstructured":"MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, Kittner SJ (2007) Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 38:2438\u20132445","journal-title":"Stroke"},{"key":"896_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0333102412451361","volume":"32","author":"S Sacco","year":"2012","unstructured":"Sacco S, Ricci S, Carolei A (2012) Migraine and vascular diseases: potential implications for management. Cephalalgia 32:785\u2013795","journal-title":"Cephalalgia"},{"key":"896_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11886-014-0524-1","volume":"16","author":"S Sacco","year":"2014","unstructured":"Sacco S, Kurth T (2014) Migraine and the risk of stroke and cardiovascular disease. Curr Cardiol Rep 16:524","journal-title":"Curr Cardiol Rep"},{"key":"896_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s10194-017-0815-1","volume":"18","author":"S Sacco","year":"2017","unstructured":"Sacco S, Merki-Feld GS, \u00c6gidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard \u00d8, MacGregor EA, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2017) HCs and risk of ischemic stroke in women with migraine: a consensus statement from the European headache federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 18:108","journal-title":"J Headache Pain"},{"key":"896_CR23","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"896_CR24","unstructured":"The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system http:\/\/gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html (Accessed, June 12, 2018)"},{"key":"896_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Sch\u00fcnemann HJ (2011a) GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol 64:407\u2013415","journal-title":"J Clin Epidemiol"},{"key":"896_CR26","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Sch\u00fcnemann HJ; GRADE Working Group (2011b) GRADE guidelines: 9. Rating up the quality of evidence J Clin Epidemiol 64:1311\u20131316","DOI":"10.1016\/j.jclinepi.2011.06.004"},{"key":"896_CR27","volume-title":"The RAND\/UCLA appropriateness method user\u2019s manual","author":"K Fitch","year":"2001","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR (2001) The RAND\/UCLA appropriateness method user\u2019s manual. RAND Corporation, Santa Monica, CA"},{"key":"896_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1378\/chest.129.1.174","volume":"129","author":"G Guyatt","year":"2006","unstructured":"Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Zelman Lewis S, Sch\u00fcnemann H (2006) Grading strength of recommendations and quality of evidence in clinical guidelines. Report from an American College of Chest Physicians task force. Chest 129:174\u2013181","journal-title":"Chest"},{"key":"896_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.fertnstert.2011.05.089","volume":"96","author":"A Alm\u00e9n-Christensson","year":"2011","unstructured":"Alm\u00e9n-Christensson A, Hammar M, Lindh-\u00c5strand L, Landtblom AM, Brynhildsen J (2011) Prevention of menstrual migraine with perimenstrual transdermal 17-\u03b2-estradiol: a randomized, placebo-controlled, double-blind crossover study. Fertil Steril 96:498\u2013500","journal-title":"Fertil Steril"},{"key":"896_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/jwh.2013.4485","volume":"23","author":"AL Coffee","year":"2014","unstructured":"Coffee AL, Sulak PJ, Hill AJ, Hansen DJ, Kuehl TJ, Clark JW (2014) Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines. J Women's Health (Larchmt) 23:310\u2013317","journal-title":"J Women's Health (Larchmt)"},{"key":"896_CR31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","volume":"293","author":"B DeLignieres","year":"1986","unstructured":"DeLignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG (1986) Prevention of menstrual migraine by percutaneous estradiol. Br Med J 293:1540","journal-title":"Br Med J"},{"key":"896_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/09513598809023619","volume":"2","author":"L Dennerstein","year":"1988","unstructured":"Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M (1988) Menstrual migraine: a double blind trial of percutaneous estradiol. Gynecol Endocrinol 2:113\u2013120","journal-title":"Gynecol Endocrinol"},{"key":"896_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10194-007-0417-4","volume":"8","author":"M Guidotti","year":"2007","unstructured":"Guidotti M, Mauri M, Barilla C, Guidotti F, Belloni C (2007) Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine. J Heachache Pain 8:283\u2013288","journal-title":"J Heachache Pain"},{"key":"896_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1783\/147118902101195974","volume":"28","author":"EA MacGregor","year":"2002","unstructured":"MacGregor EA, Hackshaw A (2002) Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 28:27\u201331","journal-title":"J Fam Plann Reprod Health Care"},{"key":"896_CR35","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67:2159\u20132163","journal-title":"Neurology"},{"key":"896_CR36","first-page":"1044","volume":"46","author":"A Magos","year":"1983","unstructured":"Magos A, Zilkha KJ, Studd JW (1983) Treatment of menstrual migraine by oestradiol implants. JNNP 46:1044\u20131046","journal-title":"JNNP"},{"key":"896_CR37","first-page":"129","volume-title":"New advances in headache research","author":"A Pradalier","year":"1994","unstructured":"Pradalier A, Vincent D, Beaulieu P, Baudersson G, Launey J-M (1994) Correlation between estradiol plasma level and therapeutic effect on menstrual migraine. In: Rose F (ed) New advances in headache research. Smith-Gordon, London, pp 129\u2013132"},{"key":"896_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1526-4610.1994.hed3402103.x","volume":"34","author":"VG Smite","year":"1993","unstructured":"Smite VG, van der Meer YG, Pfeil JPJM, Rijnierse JJMM, Vos AJM (1993) Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 34:103\u2013106","journal-title":"Headache"},{"key":"896_CR39","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.fertnstert.2011.07.1089","volume":"96","author":"V De Leo","year":"2011","unstructured":"De Leo V, Scolaro V, Musacchio MC, Di Sabatino A, Morgante G, Cianci A (2011) Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril 96:917\u2013920","journal-title":"Fertil Steril"},{"key":"896_CR40","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.fertnstert.2004.12.048","volume":"83","author":"KD LaGuardia","year":"2005","unstructured":"LaGuardia KD, Fisher AC, Bainbridge JD, LoCoco JM, Friedman AJ (2005) Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 83:1875\u20131877","journal-title":"Fertil Steril"},{"key":"896_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/01443615.2016.1234438","volume":"37","author":"GS Merki-Feld","year":"2017","unstructured":"Merki-Feld GS, Imthurn B, Dubey R, S\u00e1ndor PS, Gantenbein AR (2017) Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: how strong is the effect of taking women off combined contraceptives? J Obstet Gynaecol 37:338\u2013341","journal-title":"J Obstet Gynaecol"},{"key":"896_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.contraception.2010.07.024","volume":"83","author":"RE Nappi","year":"2011","unstructured":"Nappi RE, Sances G, Allais G, Terreno E, Benedetto C, Vaccaro V, Polatti F, Facchinetti F (2011) Effects of an estrogen-free, desogestrel containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception 83:223\u2013228","journal-title":"Contraception"},{"key":"896_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.contraception.2013.02.001","volume":"88","author":"RE Nappi","year":"2013","unstructured":"Nappi RE, Terreno E, Sances G, Martini E, Tonani S, Santamaria V, Tassorelli C, Spinillo A (2013) Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM). Contraception 88:369\u2013375","journal-title":"Contraception"},{"key":"896_CR44","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","volume":"97","author":"AH Calhoun","year":"2004","unstructured":"Calhoun AH (2004) A novel specific prophylaxis for menstrual-associated migraine. South Med J 97:819\u2013822","journal-title":"South Med J"},{"key":"896_CR45","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1526-4610.2012.02211.x","volume":"52","author":"A Calhoun","year":"2012","unstructured":"Calhoun A, Ford S, Pruitt A (2012) The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache 52:1246\u20131253","journal-title":"Headache"},{"issue":"6","key":"896_CR46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM (2016) Progestin-only contraception and thromboembolism: a systematic review. Contraception 94(6):678\u2013700","journal-title":"Contraception"},{"key":"896_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1212\/01.wnl.0000196481.57994.09","volume":"66","author":"K Aegidius","year":"2006","unstructured":"Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ (2006) Oral contraceptives and increased headache prevalence: the head-HUNT study. Neurology 66:349\u2013353","journal-title":"Neurology"},{"key":"896_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1526-4610.1993.hed3307385.x","volume":"33","author":"F Granella","year":"1993","unstructured":"Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC (1993) Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 33:385\u2013389","journal-title":"Headache"},{"key":"896_CR49","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","volume":"20","author":"F Granella","year":"2000","unstructured":"Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G (2000) Migraine with aura and reproductive life events: a case control study. Cephalalgia 20:701\u2013707","journal-title":"Cephalalgia"},{"key":"896_CR50","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10194-012-0475-0","volume":"13","author":"N Karl\u0131","year":"2012","unstructured":"Karl\u0131 N, Baykan B, Erta\u015f M, Zarifo\u011flu M, Siva A, Saip S, Ozkaya G, Turkish Headache Prevalence Study Group, Onal AE (2012) Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain 13:557\u2013565","journal-title":"J Headache Pain"},{"key":"896_CR51","doi-asserted-by":"crossref","unstructured":"Machado RB, Pereira AP, Coelho GP, Neri L, Martins L, Luminoso D (2010) Epidemiological and clinical aspects of migraine in users of combined oral contraceptives. Contraception 81:202\u2013208","DOI":"10.1016\/j.contraception.2009.09.006"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-018-0896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-018-0896-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-018-0896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T16:15:44Z","timestamp":1720541744000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-018-0896-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1186\/s10194-018-0896-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733930512.793555119","asserted-by":"object"}]},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"4 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate was not needed for this consensus.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final version and gave their approval for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the panel members has stock options or is an employee of any industry involved in the present document. Other conflicts of interest including honoraria\/expenses, consulting\/advisor boards, funded research): Simona Sacco: Allergan, Bayer Heathcare, Medtronic.Gabriele S Merki-Feld: Bayer HealthCare, HRA Pharma, MSD, Teva.Karen Lehrmann \u00c6gidius: no competing interests.Johannes Bitzer: Bayer HealthCare, Merck, Gedeon Richter, B\u00f6hringer Ingelheim, Lilly, Actavis, Allergan, Menarini, Mithra, Exeltis, Janssen, Teva.Marianne Canonico: no competing interests. Andreas R Gantenbein: no competing interests. Tobias Kurth: Novartis, Allergan, CoLucid, Novartis. Christian Lampl: no competing interests. \u00d8jvind Lidegaard: no competing interests. E Anne MacGregor: Consilient Health, Bayer HealthCare. Antoinette MaassenVanDenBrink: Amgen, ATI, CoLucid, Lilly, Novartis. Dimos-Dimitrios Mitsikostas: Allergan, Amgen, Biogen, Brain Therapeutics, Cefaly Technology, Genesis Pharma, ElectroCore, Eli Lilly, Novartis, Roche, Sanofi-Genzyme, Teva. Rossella Elena Nappi: Bayer HealthCare, Endoceutics, Exceltis, Gedeon Richter, HRA Pharma, MSD, Novo Nordisk, Pfizer, Shionogi, Teva. George Ntaios: Amgen, Bayer HealthCare, Boehringer-Ingelheim, BMS\/Pfizer, Elpen, Galenica, Medtronic, Sanofi, Winmedica. Koen Paemeleire: Allergan, Almirall, Amgen\/Novartis, Autonomic Technologies Inc., Coherex, Janssen-Cilag, Lilly, Medtronic, Pfizer, Sandoz, Sanofi, St Jude Medical and Teva.Per Morten Sandset: no competing interests. Gisela Terwindt: no competing interests. Kjersti Gr\u00f8tta Vetvik: Novartis, Roche. Paolo Martelletti: Allergan, Amgen, Electrocore, Eli Lilly, Novartis, Springer HealthCare, Teva.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"76"}}